Dosages

Likely Effective

• Age-related cataract prevention—likely to lower the risk A1, A2
• Cervical cancer—likely to lower the risk of cervical cancer F1
• Chemotherapy-induced peripheral neuropathy—likely to prevent G1
• Diabetes —likely to improve blood glucose, blood fat, and insulin levels J1-J3
• Heart attack—likely to lower risk N1
• Nonalcoholic fatty liver disease—likely to improve liver function U1

May Be Effective

• Diabetic kidney disease—may improve early kidney damage K1
• Knee osteoarthritis—may improve pain and mobility P1
• Macular degeneration —may slow disease progression R1, R2

May Not Be Effective

• Eczema —may not provide benefit D1
• Dysmenorrhea —may not ease symptoms L1
• Female subfertility—may not provide benefit M1
• Liver disease—may not provide benefit Q1
• Mild cognitive impairment—may not lower the risk of getting dementia S1
• Miscarriage—may not prevent miscarriage T1

Unlikely to Be Effective

• Cardiovascular disease —unlikely to prevent E1-E3
• Helicobacter pylori infection—unlikely to ease infection O1
• Pre-eclampsia —unlikely to prevent V1
• Pregnancy Support —unlikely to promote health of the fetus W1
• Stroke —unlikely to prevent X1

Not Enough Data to Assess

• Alzheimer Disease B1
• Asthma C1, C2
• Cognitive function H1
• Cystic fibrosis I1
• Tardive dyskinesia Y1